(BBIO) – Management Comments
-
BridgeBio Pharma Inc. (BBIO) Reports Q1, Provides Business Update
-
BridgeBio Pharma (BBIO) Announces Progress in its KRAS Portfolio, New Gene Therapy Programs, and Updates on Advancements Across its R&D Pipeline
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to BBIO Stock Lookup